Arthneeti

Paushak Q2 FY27 Share Price & Earnings Call Analysis

₹609.10+0.47% today
Market cap
₹1,502 Cr
P/E
31.76
ROE
6.98%
PEG
-2.48
Price to sales
5.43
Debt to equity
0.13
52W high / low
₹826 / ₹345
Sales growth (5Y)
9.17%
EBITDA margin
28.95%
Net profit margin
15.27%
Promoter holding
67.28%
Sales (last year)
₹277 Cr

Paushak is India’s largest phosgene based specialty chemicals manufacturer serving pharmaceutical, agrochemical and performance industries. Paushak is part of the Alembic group of companies situated in Gujarat, India.. Alembic Ltd is the oldest pharmaceutical company in India founded in 1907. [1][2]

Potential multibaggers · Q2 FY27

Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance

  1. Strong growth
    2
  2. Strong growth
    1
  3. Strong growth
    3
See all potential multibaggersWhere does Paushak rank?

Portfolio builder

Build your portfolio
from the top-ranked stocks

  1. 1. Pick 3–15 stocks
  2. 2. Choose large, mid or small cap and your sectors
  3. 3. Get a portfolio built from the rankings
Build my portfolio

Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.

Peers

Chemicals & Petrochemicals companies ranked on guidance

#CompanyRevenue guidedMargin guidedMarket capP/E
140%+Up 0–2%₹234 Cr3.0
240%+Flat₹3,888 Cr48.5
340%+Flat₹3,514 Cr4.3
440%+Flat₹180 Cr11.9
540%+Flat₹138 Cr15.1
620–40%Up 2%+₹1.70L Cr85.4

Sign up free to see every company in the sector ranking and track Paushak.

Pro shows every company guiding 40%+ revenue growth →Full Chemicals & Petrochemicals ranking

Financials of Paushak

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Shareholder Pattern

Paushak

Shareholding breakup across reporting periods.

Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Promoters +66.97%66.97%66.97%66.97%66.97%67.14%67.14%67.28%67.28%67.28%67.28%67.28%
FIIs +0.02%0.02%0.00%0.00%0.00%0.01%0.00%0.00%0.00%0.00%0.00%0.11%
DIIs +0.11%0.20%0.29%0.34%0.39%0.53%0.53%0.70%0.67%0.25%0.06%0.27%
Public +32.89%32.81%32.74%32.70%32.64%32.33%32.34%32.02%32.05%32.48%32.66%32.35%
No. of Shareholders21,59222,50321,55021,47320,74820,28620,17522,01321,73721,41921,39920,725

Financials of Paushak

Quarterly Results

Quarter-by-quarter operating performance

Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Sales +52525452574952565949558489
Expenses +38333540403536384437385863
Operating Profit14191912171516181511172626
OPM %28%36%35%23%30%30%30%32%25%23%30%31%30%
Other Income +7374460211832
Interest0000000000111
Depreciation3344444445888
Profit before tax1818231217171216117161919
Tax %25%26%19%17%16%11%21%23%24%17%22%21%27%
Net Profit +131418101415101296131514
EPS in Rs5.425.547.424.195.776.203.904.893.502.505.076.125.48

Financials of Paushak

Profit & Loss

Annual income statement trend

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales +697872105140138141150212206211219277
Expenses +5261607599959196137142151158197
Operating Profit17171229404350547565606180
OPM %25%22%17%28%29%31%36%36%35%31%28%28%29%
Other Income +3353137651120141214
Interest0000000000014
Depreciation233344591314152130
Profit before tax18171429494552507271595061
Tax %28%25%22%26%20%23%28%25%25%23%16%22%
Net Profit +13121121393537385454493947
EPS in Rs5.074.854.278.3915.8414.1915.1615.2921.9622.0920.0715.9519.17
Dividend Payout %7%8%9%4%4%5%5%10%10%11%12%16%

Financials of Paushak

Balance Sheet

Capital structure and asset base

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital333333333331212
Reserves546580110174224269302351405462479504
Borrowings +0101000000257768
Other Liabilities +111311313643576161738192100
Total Liabilities698294144214270329367415481572660684
Fixed Assets +18203537384151147149152141377375
CWIP112016166887291902616
Investments19183353116163154151182223139150168
Other Assets +30312654545056617877102107126
Total Assets698294144214270329367415481572660684

Financials of Paushak

Cash Flows

Operating, investing and financing cash movement

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +91412102441304443563854
Cash from Investing Activity +-8-13-11-10-0-39-29-42-38-50-57-95
Cash from Financing Activity +-1-1-2-1-23-2-2-2-4-51942
Net Cash Flow00-0000-1-000-10
Free Cash Flow0-3751327-26-42817-122-34
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit77%104%118%56%85%116%85%98%73%107%82%97%

Financials of Paushak

Ratios

Working capital efficiency and return ratios

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days11497831358569859790909492
Inventory Days96117125118122131148233180177179292
Days Payable941047017073110118227122130167245
Cash Conversion Cycle1161101388313389115103149137107139
Working Capital Days108929210710075608193848064
ROCE %32%25%12%29%27%21%20%17%21%17%11%8%
42out of 100

Momentum score · price trend

42 out of 100 — Steady

Over the past year its share price has moved roughly in the middle of the stocks we track.

PeriodShare price changeBetter than … of 1,910 stocks
Last 12 months+11.5%69%
Last 6 months+63.1%92%
Last 3 months+50.5%97%

The price is 44.5% below its all-time high of ₹1,494.41 (13 Apr 2022). Stocks more than 20% below their peak have their score halved, so 84 became 42.

How we calculate it

“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,910 Indian companies worth ₹500 Cr or more, with at least a year of prices).

The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For Paushak: 0.4 × 69 + 0.4 × 92 + 0.2 × 97 = 84, halved to 42 because the price is more than 20% below its all-time high.

Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.

Full methodology →

This describes only how the share price has moved up to 16 Oct 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.

Continue your research

What Paushak's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

  • J.G.Chemicals (Q2 FY27)

    Q2 FY27 Revenue from Operations: ₹3,610 million, up 63.9% YoY (₹2,203 million in Q2 FY26) (Page 23) . Key investor presentation takeaways from J.G.Chemicals Ltd

  • Lords Chloro (Q2 FY27)

    115.40 Crore, up 17.34% YoY from Rs. Key investor presentation takeaways from Lords Chloro Alkali Ltd's Q2 FY27 investor presentation — and how it ranks against

  • Camlin Fine (Q2 FY27)

    Q2 FY27 revenue: Rs 4,915 mn, up 9.15% YoY from Rs 4,503 mn in Q2 FY26 (Page 6, 9) . Key investor presentation takeaways from Camlin Fine Sciences Ltd's Q2 FY27

  • Gujarat Fluoroch (Q2 FY27)

    Consolidated Q2FY27 revenue: ₹1,760 crore, up 45% YoY (Q2FY26: ₹1,210 crore). Key investor presentation takeaways from Gujarat Fluorochemicals Ltd's Q2 FY27 inv

Compare:vs Solar Industriesvs Pidilite Industriesvs SRF